As a result, a statistically significant risk with adjusted OR of 3.65 (95%CI, 2.22–6.00, p < 0.0001) was found in gastric cancer, while no significant association of H-RAS T81C polymorphism with colon cancer and rectal cancer was observed. Here, HRAS is linked to malignant colon neoplasm.